Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Resverlogix : IIROC Trade Resumption - Resverlogix Corp.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:33pm CET

Toronto, Ontario--(Newsfile Corp. - October 13, 2017) - Trading resumes in:

Company:

Resverlogix Corp.

TSX Symbol:

RVX (all issues)

Resumption Time (ET):

10:00

 

 

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

- 30 -

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

© Newsfile Corp, source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
12/07 Resverlogix Repays $68.8 Million Loan
12/05 RESVERLOGIX : Closes Previously Announced $87 Million Private Placement with She..
12/04 Resverlogix Closes Previously Announced $87 Million Private Placement with S..
12/04 RESVERLOGIX : Closes Previously Announced $87 Million Private Placement with She..
11/02 RESVERLOGIX : Announces Fifth Positive Recommendation From Data Safety Monitorin..
11/02 Resverlogix Announces Participation in Upcoming Conferences
11/01 Resverlogix Announces Fifth Positive Recommendation From Data Safety Monitori..
10/26 RESVERLOGIX : Announces right of first refusal agreement with hepalink usa inc
10/25 RESVERLOGIX : Announces Right of First Refusal Agreement with Hepalink USA Inc.
10/24 RESVERLOGIX : Announces Right of First Refusal Agreement with Hepalink USA Inc.
More news
News from SeekingAlpha
11/08 Resverlogix (RVXCF) Presents At BIO-Europe-23rd Annual International Partneri..
10/22 WEEK IN REVIEW : WuXi AppTec Acquires U.S.-Global Clinical CRO
10/18 Resverlogix (RVXCF) Presents At 2017 BIO Investor Forum - Slideshow
10/13 Resverlogix secures $87M private capital raise
07/16 WEEK IN REVIEW : BGI Genomics Completes $81-Million Chi-Next IPO
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.31.74%196
CELLTRION, INC.--.--%22 034
IQVIA HOLDINGS INC32.81%21 333
INCYTE CORPORATION-6.46%20 382
LONZA GROUP54.74%19 270
ALNYLAM PHARMACEUTICALS, INC.239.21%12 871